Prognostic significance of microinvasion with ductal carcinoma in situ of the breast: a meta-analysis
Authors:
Open Access
- 24 November 2022
- journal article
- review article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 197 (2) , 245-254
Abstract
Purpose: Ductal carcinoma in situ (DCIS) associated with invasive carcinoma ≤ 1 mm in size is defined as DCIS with microinvasion (DCIS/microinvasion) rather than as invasive breast carcinoma. The number of patients with microinvasion accounts for < 1% of all breast cancer in published studies. As the numbers are limited, the prognostic significance of DCIS/microinvasion has not been clearly elucidated. This meta-analysis aimed to investigate the survival differences between patients with DCIS/microinvasion and those with pure DCIS. Methods: A meta-analysis following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) methodology was performed. We searched three electronic databases (MEDLINE, Cochrane Library, and EMBASE) and included observational studies published in English that contained survival details of patients with either DCIS or DCIS/microinvasion. Results: This study identified 26 studies that described the clinicopathological characteristics of patients in both the DCIS and DCIS/microinvasion groups. Survival differences were evaluated in 10 of 26 studies. Disease-free survival and loco-regional recurrence-free survival were significantly shorter in patients with DCIS/microinvasion than in those with DCIS (Hazard ratio, 1.52; 95% confidence interval, 1.11–2.08; p = 0.01 and hazard ratio, 2.53; 95% confidence interval, 1.45–4.41; p = 0.001, respectively). Both overall survival and distant metastasis-free survival tended to be shorter in patients with DCIS/microinvasion than in patients with DCIS (Hazard ratio, 1.63; 95% CI, 0.63–4.23; p = 0.31 and hazard ratio, 1.85; 95% confidence interval, 0.74–4.66; p = 0.19, respectively) but the difference was not statistically significant. Conclusion: Our meta-analysis suggests that DCIS/microinvasion may display more aggressive biological and clinical behavior than pure DCIS, highlighting the potential need for closer follow-up and consideration of adjuvant treatment strategies in DCIS patients with microinvasive disease.Keywords
Funding Information
- Japan Society for the Promotion of Science Overseas Challenge Program for Young Researchers
This publication has 40 references indexed in Scilit:
- Microinvasive Breast Cancer: ER, PR, and HER-2/neu Status and Clinical Outcomes after Breast-Conserving Therapy or MastectomyAnnals of Surgical Oncology, 2012
- Ductal Carcinoma In Situ With Microinvasion: Prognostic Implications, Long-Term Outcomes, and Role of Axillary EvaluationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Different Distribution of Breast Cancer Subtypes in Breast Ductal Carcinoma in situ (DCIS), DCIS with Microinvasion, and DCIS with Invasion ComponentAnnals of Surgical Oncology, 2010
- Microinvasive Carcinoma of the BreastPathology and Oncology Research, 2008
- Practical methods for incorporating summary time-to-event data into meta-analysisTrials, 2007
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast CancerJournal of Clinical Oncology, 2007
- Pathologic findings from the Breast Cancer Surveillance ConsortiumCancer, 2006
- The natural history of ductal carcinoma in situ of the breast: a reviewBreast Cancer Research and Treatment, 2005
- Sentinel Lymph Node Biopsy: Is It Indicated in Patients With High-Risk Ductal Carcinoma-In-Situ and Ductal Carcinoma-In-Situ With Microinvasion?Annals of Surgical Oncology, 2000
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991